Why a Buyout Deal May Not Be in the Cards for Acadia Post author:Sam Post published:November 27, 2017 Post category:BioPharma A look at why a potential buyout of Acadia might not be as likely as some have suggested. Source: BioSpace You Might Also Like New Jersey's Leading Pharma, LLC Scores $40M January 7, 2018 Insulet, Mayo Clinic Jump in On $35 Million Series C Funding Round June 27, 2017 BBI Solutions & Dr Consider International Standards For Cancer Biomarkers March 23, 2017